SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-18-004221
Filing Date
2018-05-08
Accepted
2018-05-08 07:41:15
Documents
5
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 50366
2 EX-99.1 ex-99d1.htm EX-99.1 154699
3 EX-99.2 ex-99d2.htm EX-99.2 29668
4 GRAPHIC ex-99d1g001.jpg GRAPHIC 7129
5 GRAPHIC ex-99d2g001.jpg GRAPHIC 7129
  Complete submission text file 0001558370-18-004221.txt   255857
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37691 | Film No.: 18812977
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences